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Summary 
Many diverse activities of tumor necrosis factor (TNF) 
are signaled through TNF receptor 1 (TNFRl). We have 
identified a novel 34 kDa protein, designated TRADD, 
that specifically Interacts with an Intracellular domain 
of TNFRl known to be essential for mediating pro- 
grammed cell death. Overexpression of TRADD leads 
to two major TNF-Induced responses, apoptosis and 
activation of NF-KB. The C-terminal 118 amlno acids of 
TRADD are sufficient to trigger both of these activities 
and likewise sufficient for Interaction with the death 
domain of TNFRl. TRADD-mediated cell death can be 
suppressed by the crmA gene, which encodes a spe- 
cific Inhibitor of the interleukin-1 f&converting enzyme. 
However, NF-KB activation by TRADD is not Inhibited 
by crmA expression, demonstrating that the signaling 
pathways for TNF-Induced cell death and NF-KB actl- 
vation are distinct. 
Introduction 
Tumor necrosis factor (TNF) is a pleiotropic cytokine 
whose varied biological activities are signaled through two 
distinct cell surface receptors (reviewed by Tartaglia and 
Goeddel, 1992). These receptors, termed TNFRl and 
TNFRP, are of approximate masses 55 kDa and 75 kDa, 
respectively, and are expressed on most cell types 
(Loetscher et al., 1990; Schall et al., 1990; Smith et al., 
1990). The primary amino acid sequences of the intracellu- 
lar domains bear no detectable similarity, leading to the 
prediction that the two receptors interact with different pro- 
teins and activate distinct signal transduction pathways 
(Lewis et al., 1991). Gene knockout experiments (Pfeffer 
et al., 1993; Rothe et al., 1993; Erickson et al., 1994) and 
studies with receptor-specific agonistic antibodies (Engel- 
mann et al., 1990; Espevik et al., 1990; Tartaglia et al., 
1991; Wong et al., 1992; Gehret al., 1992) haveconfirmed 
this prediction and demonstrated that the two TNF recep- 
tors generate largely nonoverlapping signals. The majority 
of the known activities of TNF have been attributed to 
TNFRl. Direct signaling through TNFR2 occurs less ex- 
tensively and appears to be mainly confined to cells of the 
immune system. 
The two TNF receptors are members of the growing TNF 
receptor superfamily, which includes the Fas antigen and 
CD40 (reviewed by Smith et al., 1994). The binding to 
these receptors of their respective ligands induces recep- 
toroligomerization and is thought to link receptors to down- 
stream signaling pathways (reviewed by Tattaglia and 
Goeddel, 1992; Smith et al., 1994). However, direct cou- 
pling to such pathways has not yet been demonstrated. 
A potential breakthrough in this regard was the identifica- 
tion of two related proteins, TRAFl and TFtAFP (for TNF 
receptor-associated factors 1 and 2, respectively), that 
form a heterodimeric complex and associate with the cyto- 
plasmic domain of TNFRP (Rothe et al., 1994). TRAFl 
and TRAF2 share a novel region of homology, the TRAF 
domain. A third member of this protein family, designated 
CD40bp or TRAF3, has recently been shown to associate 
with the cytoplasmic domain of CD40 (Hu et al., 1994). 
However, the actual contributions of the TRAFs to signal 
transduction by TNFR2 and CD40 remain unresolved. 
TNFRl is responsible for most of the biological proper- 
ties of TNF, including programmed cell death, antiviral 
activity, and activation of the transcription factor NF-KB 
in a wide variety of cell types (Engelmann et al., 1990; 
Espevik et al., 1990; Tartaglia et al., 1991; Wong et al., 
1992; Tattaglia et al., 1993). It also plays an essential role 
in host defense against microorganisms and bacterial 
pathogens (Pfeffer et al., 1993; Rothe et al., 1993). Muta- 
genesis studies have identified a so-called death domain 
of approximately 80 amino acids near the C-terminus of 
TNFRl that is required for signaling antiviral activity and 
cell death (Tartaglia et al., 1993) as well as for NF-KB 
activation (Y.-F. Hu and D. V. G., unpublished data). The 
death domain of TNkRl also triggers activation of an endo- 
somal acidic sphingomyelinase (Wiegmann et al., 1994). 
A homologous domain that can also initiate programmed 
cell death is found in the Fas antigen (Itoh and Nagata, 
1993). The apoptosis induced by both TNF and Fas was 
recently shown to involve the activation of the interleukin- 
lj3-converting enzyme (ICE) or an ICE-like cysteine prote- 
ase (Tewari and Dixit, 1995). 
The TNFRl-associated proteins involved in generating 
the various TNF-induced signals remain unknown, although 
coimmunoprecipitation experiments have revealed that 
three phosphoproteins and a serine protein kinase activity 
associate with TNFRl following TNF treatment (VanArs- 
dale and Ware, 1994). In this report, we describe the mo- 
lecular cloning of TNFRl-associated death domain protein 
(TRADD), a novel protein that interacts specifically with 
the death domain of TNFRl . Overexpression of TRADD 
activates two major TNF signaling pathways, apoptosis, 
and NF-KB activation. Furthermore, the ICE inhibitor en- 
coded by the cowpox virus crmA gene protects against 
TRADD-mediated cell death. However, crmA does not pre- 
vent TRADD-induced NF-KB activation, demonstrating 
that the two signaling pathways emanating from TRADD 
are distinct. 
Results 
Isolation of cDNA Clones Encoding 
TNFRl-Interacting Proteins 
To identify proteins that directly interact with the intracellu- 
lar region of human TNFRl, we used the yeast two-hybrid 
system (Fields and Song, 1989). From approximately 50 
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Figure 1. Predicted Amino Acid Sequence of TRADD 
The amino acid sequence deduced from the sequence of two full- 
length TRADD cDNAs is shown. The three clones isolated by two- 
hybrid screening were fused to Gal4ad at the positions indicated by 
HlO, 827, and 836. 
million transformants, 46 positive clones, as determined 
by activation of his and IacZ reporter genes, were ob- 
tained. Of these clones, 41 encoded portions of the cyto- 
plasmic region of TNFRl , indicating that the death domain 
(Tartaglia et al., 1993) of the receptor can self-associate. 
Similar findings using the yeast two-hybrid system were 
reported recently (Song et al., 1994; Boldin et al., 1995). 
Three of the remaining seven clones (HlO [219 amino 
acids], 627 (194 amino acids], and 836 [116 amino acids]) 
were partial-length cDNAs derived from the same gene. 
We screened human umbilical vein endothelial cell (HU- 
VEC) and HeLa cDNA libraries by using the 827 cDNA 
as probe and obtained four cDNAs of approximately 1.5 
kb. DNA sequence analysis of these clones revealed an 
open reading frame predicted to encode a protein of 312 
amino acids (Figure 1) with a molecular mass of 34.2 kDa 
that we have designated TRADD. Database searches uti- 
lizing BLAST and FASTA programs failed to identify any 
proteins having significant sequence similarity to TRADD. 
Detection of TRADD mRNA and Protein 
Northern blot analysis indicated that low amounts of 
TRADD mRNA were expressed constitutively in all human 
tissuesexamined (Figure2A). This result isconsistentwith 
TRADD involvement in TNFRl signal transduction, as 
TNFRl mRNA is also expressed ubiquitously (Loetscher 
et al., 1990; Schall et al., 1990; Lewis et al., 1991). The 
- 1.4 kb size of the TRADD transcript confirms that the 
cDNA clones represent full-length copies of TRADD 
mRNA. 
Polyclonal antibodies against TRADD were generated 
by expressing a glutathione S-transferase (GST)-TRADD 
fusion protein in Escherichia coli and using the purified 
GST-TRADD chimera as immunogen. Rabbit anti-TRADD 
antiserum specifically recognized two proteins of approxi- 
mately34 kDa when tested by Western blot analysis using 
lysates prepared from 293 cells transiently transfected 
with a TRADD expression vector (Figure 2B). The weak 
upper band of the doublet may be a posttranslationally 
modified TRADD. Protein bands of the same size, corre- 
sponding to endogenous TRADD, could be detected in 
lysates from ECV304, HeLa, and HepG2 cells (Figure 28) 
prepared with 50-fold more cells. 
TRADD Specifically Interacts with TNFRl 
and Self-Associates 
To confirm that full-length TRADD interacts specifically 
with TNFRl, a protein consisting of the GAL4 activation 
domain fused to full-length TRADD (GAL4ad-TRADD) 
was coexpressed with the GAL4bd-TNF-Rl icd fusion 
protein in yeast strain SFY526. The GAL4ad-TRADD chi- 
mera interacted with the GAL4bd-TNF-Rl icd fusion pro- 
tein, but not with the GAL4 DNA-binding domain alone 
(Table 1). We also tested the ability of the GAL4ad-TRADD 
fusion protein to interact with receptors that are related 
to TNFRl either in terms of their structure (TNFRP and 
Fas antigen) or the signals they generate (Fas antigen 
and the type I interleukin-1 receptor [IL-l Rl]). GAL4ad- 
TRADD failed to interact with the cytoplasmic domains 
of TNFRP, IL-l Rl , or Fas antigen expressed as GAL4bd 
chimeras (Table 1). 
To examine further the specificity of the interaction be- 
tween TRADD and TNFRl, the GAL4bd was fused to two 
different C-terminal deletion mutantsof TNF-Rl icd as well 
as to the cytoplasmic domain of murine TNFRl. GAL4ad- 
TRADD interacted strongly with an active receptor mutant 
(A413-426) lacking 14 amino acids, yet interacted weakly 
with an inactive mutant (A407-426) lacking 20 amino acids 
(Table 1). These results indicate that amino acids 407- 
41 2 of TNFRl, which are required for the signaling of cell 
death (Tartaglia et al., 1993) contribute to, but are not 
required for, its TRADD interaction. TRADD also inter- 
acted with mouse TNFRl in this assay system, but more 
weakly than with the homologous human TNFRl. 
We performed in vitro biochemical assays to confirm 
the specific interaction of TNFRl with TRADD observed 
in the two-hybrid system. GST fusion proteins containing 
the cytoplasmic domains of TNFRl, TNFR2, IL-1 Rl , and 
Fas antigen were tested for interaction with %-labeled 
TRADD prepared by in vitro transcription and translation. 
TRADD associated only with the GST-TNFRl fusion pro- 
tein (Figure 3A). Furthermore, TRADD did not associate 
with a GST-TNFRl(-20) fusion protein derived from the 
inactive TNFRl A407-426 mutant. 
To determine whether TRADD exists as a monomer, we 
prepared a reverse two-hybrid construct in which TRADD 
was fused to the GAL4bd. The results of a yeast cotransfor- 
mation experiment using this construct and the GAL4ad- 
TRADD construct indicated that these two proteins inter- 
act with each other (Table 1). The simplest interpretation 
of this result is that TRADD is an oligomeric protein. 
TRADD-TNFRl Interaction in Human Cells 
Extensive mutational analysis of TNFRl has led to the 
identification of several residues in its death domain that 
are important for signaling cell death (Tartaglia et al., 
1993). To determine whether a correlation exists between 
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the ability of a TNFRl mutant to deliver a cytotoxic signal 
and to interact with TRADD, we utilized a mammalian cell 
coimmunoprecipitation assay. An expression vector that 
directs the synthesis of TRADD containing an N-terminal 
Myc epitope tag was cotransfected with various TNFRl 
constructs into human embryonic kidney 293 cells. Cell 
extracts were immunoprecipitated by using polyclonal an- 
tibodies against the extracellular domain of TNFRl, and 
coprecipitating TRADD was detected by Western blotting 
with an anti-Myc monoclonal antibody. As determined by 
this assay, TRADD specifically associates with TNFRl 
(Figure 36). Five different deletion and point mutants of 
TNFRl were also examined by this method. The two active 
mutants (A41 3-426 and A21 2-306) were able to coprecip- 
itate TRADD, whereas two of the three inactive mutants 
(A212-340 and K343, F345, R347) failed to do so. The 
third inactive mutant (A407-426) coprecipitated TRADD 
weakly in some experiments (Figure 38) and not at all 
in others (data not shown). Accordingly, it appears that 
residues throughout the -60 amino acid death domain 
of TNFRl are critical for TRADD interaction. 
Figure 2. Identification of TRADD mRNA and 
Protein 
(A) Northern blot analysis of TRADD mRNA in 
multiple human tissues. TRADD mFtNA is the 
band at - 1.4-I .5 kb. The weakly hybridizing 
bandat - 5 kb is from nonspecific hybridization 
to 2% rRNA. 
(B) Western blot analysis of TRADD protein in 
mock- and pRK-TRADD-transfected 293 cells, 
and in nontransfected ECV304, HepG2, and 
HeLa cells. Lysates were prepared from 2 x 
lOa 293 cells (lanes 1-2) or IO6 ECV304, 
HepGP, and HeLa cells (lanes 3-5) and pro- 
teins separated by SDS-PAGE on a 10% gel. 
Western blotting was performed with rabbit 
anti-TRADD antiserum. Positions of molecular 
weight standards (in kilodaltons) are shown on 
the left. An equivalent Western blot using pre- 
immune serum failed to detect any proteins in 
the 34 kDa range (data not shown). 
Overexpression of TRADD Induces Apoptosis 
One of the major activities signaled by TNF through 
TNFRl is programmed cell death or apoptosis. To investi- 
gate a possible role for TRADD in TNF-mediated 
apoptosis, 293 cells were transiently transfected with a 
TRADD expression vector and examined by phase con- 
trast microscopy 24 hr later. Those 293 cells that overex- 
pressed TRADD had obvious morphological differences 
from those transfected with a control vector (Figure 4A). 
The TRADD-expressing cells displayed the typical charac- 
teristics of adherent cells undergoing apoptosis, becoming 
rounded and condensed (average diameter - 15 urn) and 
detaching from the dish. Cells transfected with a control 
vector remained flat, with an average length of -4O- 
50 pm. 
One biochemical hallmark of apoptosis is the internu- 
cleosomal fragmentation of nuclear DNA, which results in 
a distinct laddering pattern when analyzed by gel electro- 
phoresis (Tomei and Cope, 1991). We examined nuclear 
DNA from 293 cells transfected with either a contol vector 
or with the TRADD expression vector. DNA isolated from 
Table I. Interactions between TRADD and TNFRI 
Relative 
DNA-Binding Hybrid Activation Hybrid Colony Color 5-Galactosidase Activity 
GAL4bd-TRADD GAL4ad White <l 
GAL4bd GAL4ad-TRADD White <l 
GAL4bd-TRADD GAL4ad-TRADD Blue 69 
GAL4bd-TNFRl GAL4ad-TRADD Blue 47 
GAL4bd-TNFRl(-14) GAL4ad-TRADD Blue 76 
GAL4bd-TNFRl(-20) GAL4ad-TRADD Light blue 12 
GAL4bd-muTNFR1 GAL4bd-TRADD Light blue 27 
GAL4bd-IL1 RI GAL4ad-TRADD White <l 
GAL4bd-Fas GAL4ad-TRADD White <l 
GAL4bd-TNFR2 GAL4ad-TRADD White <l 
Yeast SFY526 cells were cotransformed with expression vectors encoding various GAL4 DNA-binding domain (GAL4bd) and GAL4 transcription 
activation domain (GAL4ad) fusion proteins. Each transformation mixture was plated on two synthetic dextrose plates lacking tryptophan and 
leucine. One plate was used to perform filter assays for colony color. Colonies on the second plate from each transformation were combined (at 
least 100 colonies per plate) and grown in liquid culture. 5-Galactosidase activity was determined on the pooled colonies by the CPRG assay 
(Iwabuchi et al., 1993). 
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Figure 3. Interaction of TRADD with TNFRl 
(A) In vitro interaction of %-TRADD with the intracellular regions of 
several receptors expressed as GST fusion proteins. %-TRADD was 
incubated with purified GST fusion proteins and processed as de- 
scribed in Experimental Procedures. Positions of molecular weight 
standards (in kilodaltons) are shown. 
(B) In vivo interaction of TRADD with TNFRI mutants. 293 cells (2 x 
105) were transiently transfected with the Myc epitope-tagged TRADD 
expression vector (1 pg) and the indicated pRK-TNFRl constructs (1 
ug). After 24 hr, extracts were prepared and immunoprecipitated with 
polyclonal antibody to TNFRI. Coprecipitating Myc-TRADD was 
detected by immunoblot analysis using the anti-Myc monoclonal 
antibody. 
TRADD-expressing cells displayed a profile characteristic 
of apoptosis and closely resembled the DNA from untrans- 
fected 293 cells that were treated with TNF (Figure 48). 
It was recently shown (Tewari and Dixit, 1995) that TNF- 
induced apoptosis can be inhibited by the ICE-specific 
serpin inhibitor encoded by the cowpox crmA gene (Ray 
et al., 1992). This led us to examine the effects of crmA 
A TRADD TRADD TRADD TRADD 
pRK Control cmmA BC1~2 El0 
Table 2. Cell Death Induced by TRADD Overexpression 
Exoression 
Number of Blue Cells per Well 
Vector HeLa HepGP NIH 3T3 
pRK control 2110 f 195 214 f 16 606 f 34 
TRADD 25 f 3 1*1 lfl 
TRADD, crmA 2083 f 61 66 -c 20 625 f 17 
TRADD, Bcl-2 1151 f 74 o*o 21 f 3 
TRADD, El B 75 -c 9 o*o 5~t2 
The indicated cell lines were transiently cotransfected with pRK- 
TRADD (1 ug), pCMV+gal (0.5 ug), and 3.5 ttg of expression vector 
for crmA, 8~1-2, or El B into the various cell lines (2 x lo5 cellsrwell). 
Samples were supplemented with the pRK5 vector control to bring 
total DNA for each transfection to 5 pg. Cells were fixed and stained 
with X-Gal 36 hr after transfection. Data ( f SEM) are shown as the 
number of blue cells per 35 mm dish for at least three independent 
transfections. 
protein and other known inhibitors of apoptosis (Bcl-2 and 
adenovirus 19K ElB proteins) on TRADD-induced cell 
death. The appearance of 293 cells cotransfected with 
expression vectors encoding both TRADD and crmA was 
indistinguishable from cells transfected with a control vec- 
tor alone (Figure 4A). Conversely, coexpression of either 
the Bcl-2 or ElB gene product did not counteract the apop- 
totic effect of TRADD expression on 293 cells. Further- 
more, crmA coexpression also blocked the generation of 
TRADD-induced DNA laddering (Figure4B). These results 
are consistent with the interpretation that TRADD-induced 
apoptosis involves activation of ICE or a related protease. 
To ensure that the induction of apoptosis by TRADD 
was not a peculiarity of 293 cells, we also examined the 
effects of TRADD overexpression on HeLa, HepG2, and 
murine NIH 3T3 cells. In these cases, a 5-galactosidase 
cotransfection assay (Kumar et al., 1994) was used to ex- 
amine cell viability. Cells were transiently transfected with 
a p-galactosidase expression plasmid and the various ex- 
pression vectors described above. After 36 hr, cells were 
stained with X-Gal and positive blue cells visualized and 
Figure 4. Apoptosis Induced by TRADD Overexpression and Its Inhibition by crmA Expression 
(A) Morphology of 293 cells transiently overexpressing TRADD. Cells (2 x 10s) were transiently transfected with the indicated expression vectors 
(1 ug) and analyzed 24 hr later by phase contrast microscopy for signs of apoptosis. Scale bar, 50 pm. 
(B) DNA fragmentation in transfected 293 cells and TNF-treated 293 cells. Untransfected 293 cells (2 x 10s) were treated with 320 nM actinomycin 
D in the presence or absense of TNF (190 nglml) for 18 hr before preparation of genomic DNA. Large-scale transfections of 2 x 10s 293 cells 
were performed with the control vector pRK5 (20 ug); pRK-TRADD (5 ug) plus pRK5 (15 ug); or pRK-TRADD (5 i.tg) plus pRK-crmA (15 pg). 
After 24 hr, DNA was isolated and analyzed as described in Experimental Procedures. The positions of the size markers (in base pairs) are shown 
on the right. 
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Figure 5. Transcription Factor NF-KB is Activated by TRADD Over- 
expression 
(A) EMSA of NF-KB activation in 293 cells. 293 cells (108) were 
transfected with 10 ug of pRK5 control (lanes l-6) or pRK-TRADD 
(lanes 7-12) DNA. Cells were treated with 100 &!/ml TNF for 3 hr prior 
to harvest (lanes 4-6). Nuclear extracts were prepared 24 hr after 
transfection, and 10 ug aliquots were combined with the =P-labeled 
NF-KB oligonucleotide probe. Individual reactions were supplemented 
with a 50-fold excess of cold competitor oligonucleotide containing 
either a wild-type (lanes 2, 5, 6) or mutated (lanes 3, 6, 9) NF-KB 
sequence. Reaction mixtures were incubated with 1 ul of preimmune 
serum (lane lo), anti-p50 serum (lane 1 l), or anti-p65 serum (lane 12) 
for IO min prior to addition of probe. 
(a) Effect of TRADD expression on NF-KB activity in 293 cells deter- 
mined by an E-selectin promoter-luciferase gene reporter assay. 293 
cells (2 x 10s) were transfected with 1 ug of pElAM-luc reporter plas- 
mid, 0.5 ug of pRSV+gal, indicated amounts of pRK-TRADD. and 
enough pRK5 control plasmid to give 2.5 ug of total DNA. Luciferase 
activities were determined 24 hrs after transfection and normalized 
on the basis of 6-galactosidase expression levels. Values shown are 
averages for an experiment in which each transfection was performed 
in duplicate. 
(C) NF-KB activation by TRADD overexpression in 293, HepG2, and 
HeLa cells. Cells (2 x 10s) were transfected with 4 ug of total DNA 
as follows. Each transfection received 1 ug of pELAM-luc, 0.5 ug of 
counted. In all cell lines, a dramatic (- 1 OO-fold) reduction 
in the number of @galactosidase-positive cells was ob- 
served for the TRADD vector compared with the control 
vector (Table 2). When crmA and TRADD were coex- 
pressed, the numbers of blue HeLa and NIH 3T3 cells 
were the same as in the vector controls. Coexpression of 
crmA protected about one-third of transfected HepG2 cells 
from TRADD-induced cell death. As was seen in 293 cells, 
neither Bcl-2 nor El B expression exerted a protective ef- 
fect on TRADD-mediated apoptosis in HeLa or NIH 3T3 
cells. Bcl-2 did provide partial protection for HeLa cells 
from the effect of TRADD overexpression (Table 2). 
TRADD Overexpression Activates NF-KB 
Another important activity of TNF signaled by TNFRl is 
activation of the transcription factor NF-KB. To examine 
a possible role for TRADD in this process, we performed 
electrophoretic mobility shift assays (EMSAs) on nuclear 
extracts from transfected 293 cells. TRADD-expressing 
293 cells were found to contain a significant amount of 
activated NF-rcB even in the absense of exogenous TNF. 
In contrast, specific NF-KB complexes were detected only 
after TNF treatment in 293 cells transfected with an empty 
expression vector (Figure 5A). Supershift experiments 
performed with antibodies demonstrate that the major 
component of the activated NF-KB complex appears to 
be the p65-~50 heterodimer. 
Dose-response experiments were performed to deter- 
mine whether TRADD expression might lead to activation 
of a NF-rcBdependent reporter gene. An E-selectin-lucif- 
erase reporter construct was cotransfected with increas- 
ing amounts of the TRADD expression vector into 293 
cells. TRADD expression potently activated the reporter 
gene, with maximal luciferase activity (approximately 400- 
fold induction) occurring at a 0.32 pg dose of the TRADD 
expression vector (Figure 56). These levels of reporter 
gene induction are greater than the -26fold induction 
observed when 293 cells are treated with TNF alone (data 
not shown). Further increases in TRADD vector resulted 
in diminished levels of reporter activity, probably owing to 
induction of cell death (see below). 
CrmA Does Not Block TRADD-Induced 
NF-KB Activation 
Since crmA is a potent inhibitor of apoptosis induced by 
either TNF treatment or TRADD expression, we examined 
its effect on NF-KB activation. CrmA expression had little 
or no effect on TRADD-induced NF-KB activation in 293 
cells as determined either by EMSA (data not shown) or 
by the luciferase reporter gene assay (Figure 5C). HeLa 
and HepG2 cells were also examined for NF-KB activation 
following transient transfection with the TRADD expres- 
pRSV-pgal, and one of each of the following: 2.5 ug of pRK5 control 
vector (solid black bars); 2 ug of pRK-crmA, 0.5 ug of pRK5 (solid 
white bars); 0.5 ug of pRK-TRADD, 2 ug of pRK5 (dark shading); or 
0.5 ug of pRK-TRADD, 2 pg of pRK-crmA (light shading). Cells were 
harvested 24 hr after transfection and luciferase levels determined. 
The fold induction in luciferase activity compared with the control pRK5 
transfection is indicated. 
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Figure 6. Analysis of TRADD Deletion Mutants 
(A) Apoptosis and activation of NF-KB mediated by TRADD deletion 
mutants. The horizontal bars represent the sequence of TRADD, with 
shaded regions corresponding to intact sequences and dotted regions 
indicating deleted sequences. Apoptosis assays were performed 24 
hr after transfection of 293 cells with the indicated Myc-tagged TRADD 
constructs. Plus indicates that the majority of cells became condensed, 
rounded, and detached (as in Figure 4A), while minus indicates that 
no morphological changes were observed. NF-KB activation assays 
were performed following cotransfection of 293 cells with TRADD and 
the NF-KB reporter plasmid pELAM-luc as described in Experimental 
Procedures. Data are shown as fold increase in luciferase levels rela- 
tive to levels in 293 cells transfected with the control vector pRK5. 
(6) Interaction of “S-TRADD deletion mutants with GST-TNFRI. The 
various *S-labeled TRADD deletion mutants (equivalent counts per 
minute) were incubated with purified GST or GST-TNFRI bound to 
glutathione-Sepharose beads and processed as described in Experi- 
mental Procedures. C-terminal (lanes 1-6) and N-terminal (lanes 
7-12) deletion mutants were fractionated on 10% and 15% SDS- 
PAGE, respectively, and exposed to X-ray film for 6 hr. 
(C) In vitro interaction of YS-TRADD deletion mutants with GST- 
TRADD. Experiments were performed as described above but using 
GST-TRADD instead of GST-TNFRl. Dried gels were exposed to 
X-ray film for 5 days. 
(D) Alignment of TRADD, TNFRl , and Fas death domains. Amino 
acids 222-289 of TRADD are compared with amino acids 345-412 of 
TNFRl and 232-298 of Fas antigen. Boxes indicate identities between 
TRADD and either TNFRl or Fas. Asterisks above the sequence indi- 
cate the six individual residues where mutation to alanine has been 
shown to inactivate TNFRl signaling (Tartaglia et al., 1993). 
sion vector alone. In most experiments, no activation was 
seen in these cell lines, a result potentially attributable to 
rapid induction of cell death (see Table 2). To determine 
whether NF-KB could be activated by TRADD if cell death 
were inhibited, these cell lines were cotransfected with 
crmA and TRA DD expression vectors. While crmA expres- 
sion alone had no effect, substantial activation of NF-KB 
was observed in the crmA-TRADD cotransfection experi- 
ments (Figure 5C). These results demonstrate an inherent 
ability of TRADD to activate NF-KB, which can be more 
readily obsenred if the death pathway is blockaded by 
crmA expression. 
Deletion Mutagenesis of TRADD 
The experiments described thus far have identified four 
distinct properties of TRADD: first, interaction with TNFRl ; 
second, self-association; third, induction of apoptosis; and 
fourth, activation of NF-KB. To ascertain whether these 
properties reside in common or distinct domains of 
TRADD, we constructed a series of N-and C-terminal dele- 
tion mutants (Figure 6A). The ability of each mutant to 
induce apoptosis was determined in the 293 transient 
assays described above. A TRADD mutant (Al-194) con- 
taining only 116 C-terminal amino acids was able to trigger 
cell death, whereas a mutant (Al-204) ten amino acids 
shorter did not. Deleting from the C-terminus, a mutant 
(A301-312) lacking only 12 residues was inactive, but a 
mutant (A306312) lacking seven amino acids retained 
the ability to induce apoptosis of 293 cells. This analysis 
localized the apoptosis activation function (death domain) 
of TRADD to a 111 residue region extending from amino 
acid 195 to amino acid 305 (Figure 6A). NF-KB activation 
for each TRADD mutant was determined in the NF-KB 
reporter cotransfection assay. According to this analysis, 
the region of TRADD required for NF-KB activation was 
strictly concordant with that required for apoptosis (Fig- 
ure 6A). 
The %-labeled TRADD deletion mutants were assayed 
for association with a GST-TNFRl fusion protein (Figure 
6B). Two mutants (A30631 2 and Al-194) bound as well 
as wild-type TRADD to TNFRl. These same two mutants 
were biologically active, as determined by the apoptosis 
and NF-KB activation assays. TRADD mutants that were 
inactive in these biological assays bound TNFRl poorly 
or not at all. 
Similarly, the ability of the TRADD deletion mutants to 
self-oligomerize was assessed by use of a GST-TRADD 
fusion protein and the “S-labeled TRADD mutants (Figure 
6C). The same mutants that interacted with GST-TNFRl 
were able to bind GST-TRADD, although by this assay, 
self-association was much weaker than interaction with 
TNFRl. The one difference observed was that the biologi- 
cally inactive A301-312 mutant, which does not interact 
with TNFRl , was still able to self-associate. These results 
demonstrate that a 111 amino acid domain (amino acids 
195-305) of TRADD is capable of oligomerization, TNFRl 
interaction, stimulation of programmed cell death, and NF- 
KB activation. 
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Death Domains of TRADD and TNFRI Share 
Sequence Similarity 
Database screens failed to identify any proteins bearing 
significant similarity to the primary amino acid sequence 
of TRADD. However, since the 111 amino acid death do- 
main of TRADD shares many properties with the -80 
amino acid death domain of TNFRI , these two sequences 
were directly compared. Alignment of TRADD residues 
196-302 relative to residues 319-425 of TNFRl results 
in 25 identities over 107 amino acids (23%). The most 
obvious sequence similarity was found in the stretch of 
68 amino acids shown in Figure 6D. If a single gap is 
introduced into both sequences, 22 identities (32%) and 
21 conservative changes are found. Whereas the majority 
of the identities are leucines and arginines, three observa- 
tions indicate that the sequence similarity may be function- 
ally significant. First, six amino acids have been identified 
in the death domain of TNFRI that, when mutated to aia- 
nine, aboiishsignaling(Tartagliaet al., 1993). Fiveof these 
six amino acids, which extend to both ends of the aligned 
sequence (Figure 6D), are identical or highly conserved in 
TRADD. Second, thesequencesimilaritybetweenTRADD 
and TNFRI over this region is roughly the same as that 
between the functionally similar death domains of TNFRI 
and Fas antigen. Third, TRADD and Fas antigen, which 
appear not to interact with each other, share only nine 
identities (13%) over these 68 residues. 
Discussion 
TRADD Activates TNFRI Signaling Pathways 
The signal transduction events initiated by ligand binding 
to receptor tyrosine kinases (Schlessinger and Ullrich, 
1992) and hematopoietic cytokine receptors (Kishimoto et 
al., 1994) are now relatively well understood. In contrast, 
little is known at the molecular level about the postreceptor 
signaling mechanisms utilized by the TNF receptor super- 
family. There are now twelve known members of this fam- 
ily, yet unambiguous evidence for direct receptor coupling 
with intracellular proteinsexistsonly forTNFR2 and CD40. 
In the former instance, a heterodimer consisting of the two 
related proteins TRAFl and TRAFP associates via TRAFP 
with sequences in the TNFR2 cytoplasmic domain that 
are necessary for signal transduction (Rothe et al., 1994). 
In the latter case, another TRAF domain protein, CD4Obp 
orTRAF3, is found toassociate with CD40(Huet al., 1994). 
Most of the known pleiotropic activities of TNF are a 
consequence of TNFRl activation (Tartaglia and Goeddel, 
1992). An - 80 amino acid death domain located near the 
C-terminus of TNFRl is sufficient to initiate signals for 
apoptosis, antiviral activity, and NF-I& activation (Tartag- 
lia et al., 1993; Y.-F. Hu and D. V. G., unpublished data). 
To identify candidate proteins for evaluation as TNFRI- 
associated signaling molecules, we utilized the yeast two- 
hybrid cloning approach of Fields and Song (1989). Con- 
sistent with the work of others (Song et al., 1994; Boldin 
et al., 1995) we found that the cDNAs isolated most fre- 
quently were those encoding the death domain of TNFRl. 
We also identified TRADD, a 34 kDa protein bearing little 
resemblance to previously described proteins. 
Overexpression of TRADD in a variety of ceil lines was 
found to be a potent inducer of programmed cell death, 
mimicking the effect of TNF treatment in the presence of 
actinomycin D. TRADD-mediated apoptosis is effectively 
blocked by coexpression of the cowpox virus crmA gene, 
which encodes a protease inhibitor of the serpin class 
(Pickup et al., 1986). CrmA is a specific inhibitor of ICE 
(Ray et al., 1992), a cysteine protease involved in IL-18 
processing (Thornberly et al., 1992) and in some types of 
programmed cell death (Miura et al., 1993; Gagliardini et 
al., 1994). Significantly, crmA was recently shown to block 
the apoptosis triggered by both TNFRI and Fas antigen 
(Tewari and Dixit, 1995) suggesting ICE involvement in 
these signaling pathways as well. Therefore, it is not sur- 
prising that TRADD-mediated cell death involves ICE, or 
an ICE-related protease; this result might be expected if 
TRADD overexpression were to activate a latent TNFRl 
apoptotic pathway. 
The Fas antigen signals cell death through a portion of 
its cytoplasmic domain that is 28% identical to the death 
domain of TNFRI (itoh and Nagata, 1993). interestingly, 
TRADD does not appear to interact with Fas antigen. This 
observation suggests that the receptor-proximal apoptotic 
signaling pathways activated by TNFRI and Fas antigen 
are distinct, but converge downstream at some point be- 
fore ICE activation. Alternatively, thetwo pathways may be 
parallel and activate distinct crmA-inhibitable, ICE-related 
proteases. In either case, it is possible that a TRADD- 
related protein will be discovered that associates with the 
death domain of Fas antigen. Furthermore, both aiterna- 
tives are consistent with reports that TNF and Fas activate 
programs of ceil death that are at least partially distinct 
(Wong and Goeddel, 1994; Schuize-Osthoff et al., 1994). 
Both TNF and IL-l induce the transcriptional activation 
of a large set of genes involved in acute phase and inflam- 
matory responses by activating the transcription factor NF- 
KB. In general, the proinflammatory activity of TNF is sig- 
naled through TNFRl (Kruppa et al., 1992; Pfeffer et al., 
1993) although there are some cell lines in which TNFRP 
can activate NF-KB (Rothe et al., 1994; Lzgreid et al., 
1994). Transient overexpression of TRADD potently acti- 
vated NF-KB in several TNF-responsive cell lines. How- 
ever, in several instances this activation could be seen 
only when the cell death pathway was inhibited by crmA 
expression. Our failure to observe any interaction between 
TRADD and either IL-I Rl or TNFRP suggests that TRADD 
is not involved in NF-KB activation initiated by these two 
receptors and may be exclusively dedicated to TNFRI 
signal transduction. 
Deletion mutagenesis experiments identified a region 
of 111 amino acids near the C-terminus of TRADD that is 
sufficient to trigger both apoptosis and NF-KB activation. 
This death domain is also sufficient for interaction with 
TNFRl and self-association. Furthermore, this region is 
related in primary sequence to the death domain of 
TNFRI, but bears little similarity to the Fas antigen death 
domain. This raises the possibility that the greater se- 
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quence identity between TRADD and TNFRI defines a 
structural framework that accounts for their ability to inter- 
act specifically. 
To date, we have been unable to identify a TRADD mu- 
tant that interacts with TNFRl but fails to signal. Such a 
mutant might be expected to act as a dominant negative 
inhibitor of TNF signaling, thereby demonstrating an es- 
sential role for TRADD in TNFRl signal transduction. How- 
ever, strong correlative evidence for such a role comes 
from several observations. First, no active TRADD dele- 
tion mutants were found that failed to interact with TNFRl . 
Second, mutants of TNFRl that are incapable of signaling 
cell death or NF-ICB activation do not interact with TRADD. 
Third, two-hybrid screening using murine TNFRl as bait 
resulted in the isolation of a cDNA for murine TRADD (M. 
Pan and D. V. G., unpublished data). Finally, human 
TRADD is able to interact with the cytoplasmic domains 
of murine and human TNFRl, which do not exhibit species 
specificity, yet share only 59% sequence identity (Lewis 
et al., 1991). 
Mechanisms of TRADD-Induced 
Signal Transduction 
The disparate effects of crmA expression on TRADD- 
induced apoptosis and NF-KB activation are significant, 
as they suggest divergence of the apoptotic and NF-KB 
pathways mediated by TNFRl Furthermore, the failure 
of crmA expression to block NF-KB activation indicates 
that this aspect of TRADD activity is not an artifact of sick 
or dying cells. Apparently, the interaction of the death do- 
main of TNFRl with the C-terminal region of TRADD acti- 
vates either two separate signaling cascades or one pri- 
mary signal that subsequently splits into two (or more) 
pathways before ICE is encountered on the apoptotic 
pathway. 
Just how TRADD is able to transmit signals downstream 
from TNFRl remains a mystery at this time. Western blot 
analyses indicate that TRADD is normally expressed in 
very low amounts. On the basis of cDNA cloning results 
(approximately one positive in lo6 clones screened) and 
Northern blot analyses, we estimate that TRADD mRNA 
levels are typically less than 5 molecules per cell. Perhaps 
TRADD has a higher affinity for aggregated than for mono- 
meric TNFRl, such that under normal physiological condi- 
tions, interaction can only occur following TNF-induced 
receptor aggregation. Another possibility is that a TRADD 
or TNFRl-associated inhibitory protein prevents interac- 
tion of TRADD with TNFRl prior to receptor aggregation. 
Both possibilities might be expected to represent deli- 
cately balanced signaling systems that could be overrid- 
den by enforced expression of TRADD. Similarly, overex- 
pression of TNFRl has been shown to trigger cell death, 
IL-8 gene induction (Boldin et al., 1995), and NF-KB activa- 
tion (H. H. and D. V. G., unpublished data). In this case, 
ligand-independent aggregation of TNFRl is observed, 
which might result in recruitment of TRADD to the receptor 
complex. 
The identification and characterization of TRADD de- 
scribed herein provides an initial step in deciphering the 
intracellular signaling pathways activated by TNF binding 
to TNFRl. However, many important questions remain 
unresolved: first, what role does TRADD play in other 
TNFRl -transduced signals, such as activation of sphingo- 
myelinases or the TNFRl-associated serine kinase activ- 
ity? Second, what is the function of the -200 N-terminal 
amino acids of TRADD that are not required for induction of 
apoptosis and NF-KB activation? Third, how does TRADD 
connect to downstream signaling events? Fourth, do other 
members of the TNF receptor superfamily interact with 
TFfADD or related molecules to initiate their signaling cas- 
cades? Finally, do TRADD-like proteins participate in other 
(non-TNF receptor superfamily-mediated) pathways of 
programmed cell death? We hope that the molecular re- 
agents and observations reported herein will help stimu- 
late a resolution to these and other questions. 
Experimental Procedures 
Reagents and Cell Lines 
Recombinant human TNF was provided by Genentech, Incorporated. 
The rabbit anti-TNFRl polyclonal antibody was described previously 
(Tartaglia et al., 1991). The rabbit anti-TRADD antiserum was raised 
against a GST-TRADD fusion protein by BabCo (Richmond, Califor- 
nia). The monoclonal antibody against the Myc epitope (S-M-E-Q-K-L-I- 
S-E-E-D-L-N) was provided by R. Schreiber. Rabbit anti-p50 and anti- 
p65 polyclonal antibodies were purchased from Santa Cruz 
Biotechnology. The HtTA-1 (for HeLa expressing a tetracycline- 
controlled transactivator; Dr. H. Bujard), 293 (R. Tjian), HepGP (Ameri- 
can Type Culture Collection [ATCC]), ECV304 (ATCC), and NIH 3T3 
(S. McKnight) cell lines were obtained from the indicated sources. 
Expression Vectors 
The TRADD cDNA was cloned as a 1.4 kb EcoRl fragment into pRK5 
under the transcriptional control of the cytomegalovirus (CMV) immedi- 
ate-early promoter-enhancer (Schall et al., 1990). The resulting plas- 
mid, pRK-TRADD, was used for mammalian cell expression and for 
in vitro transcription and translation using the SP6 promoter. Myc epi- 
tope tag constucts were made by replacing the eight N-terminal codons 
of TRADD with DNA encoding the sequence M-A-SM-E-Q-K-L-I-SE-E- 
D-L. C-terminal deletion mutants of TRADD were generated by re- 
placement of sequences between the Xhol site in TRADD and the 
Hindlll site in pRK5 with synthetic DNA containing the appropriate 
coding sequence and in-frame stop codons. N-terminal deletion mu- 
tants of TRADD were generated by polymerase chain reaction (PCR). 
The various mutant T/W?7 expression vectors were described pre- 
viously (Tartaglia et al., 1993). A plasmid containing the cowpox virus 
cmA gene (Pickup et al., 1986) was obtained from G. Palumbo. A 1 .O 
kb crmA fragment was generated by PCR and inserted into the pRK5 
vector to give the plasmid pRK-crmA. The &l-Z expression vector 
pSFFV-6~1-2, based on the long terminal repeat of the splenic focus- 
forming virus, was provided by S. Korsmeyer. The &W-based expres- 
sion vector pCMV19K for the adenovirus 19 kDa El B protein was 
provided by J. Fraser. The NF-xB-luciferase reporter plasmid pELAM- 
Iuc, containing E-selectin promoter sequences from position -730 to 
position +52 (Schindler and Baichwal, 1994) was provided by U. 
Schindler. 
Yeast Two-Hybrid Cloning 
DNA encoding the intracellular domain (amino acids 214-426) of 
TNFRI was cloned into the yeast GAL4 DNA-binding domain vector 
pGBT9. The resulting plasmid, pGAL4bd-TNF-Rl icd, was used as 
bait in two-hybrid screens of HeLa and B cell cDNA libraries (Clontech) 
following the Matchmaker Two-Hybrid System Protocol (Clontech). 
Positive yeast clones were selected by prototrophy for histidine and 
expression of 5galactosidase. Yeast DNA was recovered and trans- 
formed into E. coli. Plasmids containing cDNA clones were identified 
by restriction mapping and further characterized by DNA sequencing. 
Subsequent two-hybrid interaction analyses were carried out by co- 
transformation of plasmids containing the GAL4 DNA-binding (pGBT9) 
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and -activation (pGAD424) domains into Saccharomyces cerevisiae 
strain SFY526. 
cDNA Cloning and Northern Blot Hybridization 
The cDNA insert of approximately 1 kb from two-hybrid clone 827 was 
used as probe to screen human HeLa and HUVEC cDNA libraries in 
lgtl 1 (provided by Dr. 2. Cao; complexity of >2 x I@ clones each) by 
standard methods (Sambrook et al., 1989). Two independent positive 
clones were obtained from each library. Following subcloning into 
pBluescript KS (Stratagene), DNA sequencing was performed on an 
Applied Biosystems, incorporated model 373A automated DNA se- 
quencer by use of the Prism Dye Terminator Cycle sequencing kit 
(Applied Biosystems). Northern blot analysis of the human multiple 
tissue blot (Clontech) was performed according to the instructions of 
the manufacturer, by use of an -400 bp EcoRI-Narl fragment from 
the 5’ end of TRADD cDNA as probe. 
Cell Culture, Tranefectlone, end Reporter Assays 
293 and NIH 3T3 cells were maintained in high glucose Dulbecco’s 
modified Eagle’s medium (DMEM) containing 10% fetal calf serum, 
100 pg/ml penicillin G, and 100 pg/ml streptomycin (GIBCO). HtTA-1 
(HeLa) cells were grown in the same medium containing 400 pg/ml 
G418. HepGP cells were maintained in DMEMIFIP (1:1) medium with 
the same additives. For reporter assays, coimmunoprecipitations, and 
cell killing assays, - 2 x 105 cells/well were seeded on &well (35 mm) 
dishes and grown in 5% COn at 37OC. Cells were transfected the next 
day by the calcium phosphate precipitation method (Ausubel et al., 
1994). After an incubation of 24-36 hr, cells were washed twice with 
phosphate-buffered saline and then lysed with 200 pl of lysis buffer 
(25 mM Tris-phosphate [pH 7.81, 2 mM dithiothreitol [DTT], 2 mM 
1,2-diaminocyclohexane-N,N,N’,N’-tetraacetic acid ]CDTA], 10% glyc- 
erol, 1% Triton X-100). Aliquots of cell lysates [20 1111 were mixed with 
100 pl of luciferase assay reagent (Promega) and the luciferase activity 
determined using a Model 20e luminometer (Turner Designs). P-Galac- 
tosidase activity was determined in a mixture containing IO III of cell 
@ate, IO pl of 50 mM chlorophenol red f&galactopyranoside (CPRG), 
and 60 ~1 of Z buffer (60 mM N&HPO,, 10 mM KCI, 1 mM B-mercapto- 
ethanol [pH 7.01). Samples were incubated at 37OC until red color 
developed, and absorbance was determined at 574 nm. These values 
were used to normalize transfection efficiencies. For DNA laddering 
and EMSA experiments, transfections were performed with 100 mm 
dishes seeded with - 108 cells. At 24-36 hr after transfection, DNA 
or nuclear extracts were prepared. 
Colmmunopreclpltatlone and Western Blot Analysis 
Western blot analysis to detect TRADD was performed with the anti- 
TRADD antiserum and horseradish peroxidase-coupled goat anti- 
rabbit IgG (Amersham) using enhanced chemiluminescence ac- 
cording to the protocol of the manufacturer. For immunoprecipitation 
assays, 50 ~1 aliquots of lysates from transfected cells were incubated 
with 1 pl of the anti-TNFRI antibody and 450 pl of EIA buffer (50 mM 
HEPES [pH 7.61, 250 mM NaCI, 0.1% NP-40, 5 mM EDTA). The mix- 
ture was incubated at 4OC for 1 hr, then mixed with 20 pl of a 1:1 
slurry of protein A-Sepharose (Pharmacia) and incubated for another 
hour. The beads were washed twice with 1 ml of EIA buffer, twice 
with 1 ml of high salt (1 M NaCI) ElA buffer, and twice again with EIA 
buffer. The precipitates were fractionated on 10% SDS-polyacryl- 
amide gels and transferred to lmmobilon P membrane (Millipore). The 
blot was subjected to Western blot analysis with anti-Myc monoclonal 
antibody and horseradish peroxidase-coupled rabbit anti-mouse im- 
munoglobulin. 
Generation of GST Fusion Proteins and In Vitro Blndlng Aeeays 
TRADD and the cytoplasmic regions of TNFRI, TNFRl(-20), Fas anti- 
gen, IL-I Rl, and TNFRP were expressed individually as GST (glutathi- 
one S-transferase) fusion proteins by use of pGEX vectors (Phar- 
macia). Expression and purification of the GST fusion proteins were 
performed as described (Smith and Johnson, 1988). =S-labeled pro- 
teins were generated with the TNT SP6 Coupled Reticulocyte Lysate 
System (Promega) and the various TRADD expression cunstructs in 
pRK5. For each in vitro binding assay, 10 VI of glutathione-Sepharose 
beads (Pharmacia) bound to the appropriate GST fusion protein (- 5 
pg) was incubated with %S-labeled polypeptides in 1 ml of EIA buffer 
at 4°C for 1 hr. The beads were then washed six times with EIA buffer. 
Proteins on the beads were fractionated by SDS-polyacrylamide gel 
electrophoresis (PAGE) and exposed to Kodak X-ray film. 
Apoptoele Aeeaye 
DNA fragmentation assays were performed as described (Hermann 
et al., 1994), using approximately 10’ transfected or nontransfected 
cells. DNA aliquots (150 ng) were fractionated by electrophoresis in 
a 1.6% agarose gel. 
!.I-Galactosidase cotransfection assays for determination of cell 
death were performed as described by Kumar et al. (1994). Cells were 
observed microscopically, and the number of blue cells per 35 mm 
well was determined by counting. 
EMSAe 
Nuclear extracts were prepared as described by Osborn et al. (1969). 
Double-stranded oligonucleotides (C’-GATGCCAlTGGGGAllTCCT- 
ClTTACTG) containing an NF-KB-binding site were “P-labeled using 
polynucleotide kinase. Each gel shift assay was performed in a 30 
~1 reaction mixture containing 10 pg of nuclear extracts, 0.4 ng of 
radiolabeled oligonucleotide probe, 1 pg of sonicated E. coli DNA, 6 
~1 of 5x EMSA buffer (100 mM HEPES [pH 7.6],250 mM KCI, 5 mM 
DlT, 5 mM EDTA, 25% glycerol), and where necessary, 20 pg of cold 
competitor oligonucleotides. The mutant competitor oligonucleotides 
have the underlined NF-KB site changed to GGaagcTTCC. Mixtures 
were incubated at room temperature for IO min and then subjected 
to electrophoretic fractionation on a 5% polyacrylamide gel at 4OC. 
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